Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Therapeutic Drug Carrier Systems
IF: 2.414 5-Year IF: 3.324 SJR: 0.573 SNIP: 0.551 CiteScore™: 2.43

ISSN Print: 0743-4863
ISSN Online: 2162-660X

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v18.i6.40
16 pages

In Vivo Applications of PEG Liposomes: Unexpected Observations

Peter Laverman
Department of Nuclear Medicine, University Medical Center Nijmegen, Nijmegen, The Netherlands
Otto C. Boerman
Department of Nuclear Medicine, University Medical Center Nijmegen, Nijmegen, The Netherlands
Wim J. G. Oyen
Department of Nuclear Medicine, University Medical Center Nijmegen, Nijmegen, The Netherlands
Frans H. M. Corstens
Department of Nuclear Medicine, University Medical Center Nijmegen, Nijmegen, The Netherlands
Gert Storm
Utrecht Institute for Pharmaceutical Science, Utrecht University, Utrecht, The Netherlands

ABSTRACT

Recent studies with PEG liposomes in patients have consistently shown that liposomes can induce side effects (flushing, tightness of the chest). Furthermore, the blood clearance of PEG liposomes was shown to be dose-dependent: at lipid doses lower than 1 mmol/kg, PEG liposomes do not show the long-circulation property but instead are cleared relatively rapidly from the bloodstream. Another remarkable observation was that repeated injections of PEG liposomes led to significant pharmacokinetic changes: the circulatory half-life of a second dose of radiolabeled PEG liposomes dramatically decreased when given from 5 days to up to 4 weeks after a first injection. In these three unexpected phenomena, proteins of the complement system seem to play a key role.Therefore, one has to consider that PEG liposomes are not inert drug-carrying vehicles in vivo. Pharmacological effects can occur, induced solely by using liposomal particles irrespective of the drug content.


Articles with similar content:

Capture of Stealth Nanoparticles by the Body’s Defences
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.18, 2001, issue 6
S. Moein Moghimi, Christy Hunter
Medicinal Value of Turkey Tail Fungus Trametes versicolor (L.:Fr.) Pilat (Aphyllophoromycetideae)
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
Christopher Hobbs
Polymer-Drug Conjugates for Anticancer Drug Delivery
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.32, 2015, issue 3
Saurabh Wadhwa , Russell J. Mumper
Long-Acting Injectables: Current Perspectives and Future Promise
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.36, 2019, issue 2
Komal Chaudhary, Mayur M. Patel, Priti J. Mehta
Targeting the Antigen-Binding Site of HLA-Restricting Alleles in Treatment of Autoimmune Disease
Critical Reviews™ in Immunology, Vol.27, 2007, issue 3
Philip Deitiker, M. Zouhair Atassi, Minako Oshima